Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;31(2):129-37.
doi: 10.1055/s-0034-1373788.

Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors

Affiliations
Review

Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors

Hyeon Yu et al. Semin Intervent Radiol. 2014 Jun.

Abstract

Tumor ablation is a minimally invasive technique used to deliver chemical, thermal, electrical, or ultrasonic damage to a specific focal tumor in an attempt to achieve substantial tumor destruction or complete eradication. As the technology continues to advance, several image-guided tumor ablations have emerged to effectively manage primary and secondary malignancies in the liver. Percutaneous chemical ablation is one of the oldest and most established techniques for treating small hepatocellular carcinomas. However, this technique has been largely replaced by newer modalities including radiofrequency ablation, microwave ablation, laser-induced interstitial thermotherapy, cryoablation, high-intensity-focused ultrasound ablation, and irreversible electroporation. Because there exist significant differences in underlying technological bases, understanding each mechanism of action is essential for achieving desirable outcomes. In this article, the authors review the current state of each ablation method including technological and clinical considerations.

Keywords: cryoablation; high-intensity–focused ultrasound ablation; interventional radiology; irreversible electroporation; microwave ablation; percutaneous chemical ablation; radiofrequency ablation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs A K. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33(5):437–447. - PubMed
    1. Clark T W, Soulen M C. Chemical ablation of hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13(9, Pt 2):S245–S252. - PubMed
    1. Shiina S, Tagawa K, Niwa Y. et al.Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol. 1993;160(5):1023–1028. - PubMed
    1. Lencioni R, Bartolozzi C, Caramella D. et al.Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer. 1995;76(10):1737–1746. - PubMed
    1. Livraghi T, Giorgio A, Marin G. et al.Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995;197(1):101–108. - PubMed